cabozantinib,nivolumab,ipilimumab
bms,exelixis
['/ipi', 'nivo', 'triplet,(-triplete)', 'rcc,(-irccs),(-srcc),(-urcc)', 'cosmic-313']
#esmo22 cosmic-313 presented by triplet therapy with cabo/nivo/ipi vs cabo/nivo for patients with advanced tn advanced intermediate or poor-risk #rcc. primary ep: pfs; n=855 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge